Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells

Cell Proliferation

Volumn 44, Issue 5, 2011, Pages 420-427

  Huang, H ^a   Zhao, N ^a   Xu, X ^a   Xu, Y ^b   Li, S ^a   Zhang, J ^a   Yang, P ^a  

^a SHANDONG UNIVERSITY   (China)

^b Jinan Dental Hospital (East)   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; MESENCHYMAL STEM CELL; MINERALIZATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENETIC MARKERS; I-KAPPA B PROTEINS; MESENCHYMAL STEM CELLS; MICE; NF-KAPPA B; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 80053141199     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00769.x     Document Type: Article

References (34)

1. Bartold PM, Cantley MD, Haynes DR (2010) Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000 53, 55-69.
2. Page RC (1998) The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol 3, 108-120.
3. Deo V, Bhongade ML (2010). Pathogenesis of periodontitis: role of cytokines in host response. Dent Today 29, 60-62, 64-66; quiz 68-69.
4. Gould TR, Melcher AH, Brunette DM (1980) Migration and division of progenitor cell populations in periodontal ligament after wounding. J. Periodontal Res. 15, 20-42.
5. Li S, Tu Q, Zhang J, Stein G, Lian J, Yang PS et al. (2008) Systemically transplanted bone marrow stromal cells contributing to bone tissue regeneration. J. Cell. Physiol. 215, 204-209.
6. Page RC (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J. Periodontal Res. 26, 230-242.
7. Brunetti G, Colucci S, Pignataro P, Coricciati M, Mori G, Cirulli N et al. (2005) T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients. J. Periodontol. 76, 1675-1680.
8. Li W, Yu B, Li M, Sun D, Hu Y, Zhao M et al. (2010) NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha. Biochem. Biophys. Res. Commun. 391, 1228-1233.
9. Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M et al. (2010) Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol. Cell. Endocrinol. 325, 118-127.
10. Lacey DC, Simmons PJ, Graves SE, Hamilton JA (2009) Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage 17, 735-742.
11. Li B, Shi M, Li J, Zhang H, Chen B, Chen L et al. (2007) Elevated tumor necrosis factor-alpha suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma. Stem Cells Dev. 16, 921-930.
12. Lencel P, Hardouin P, Magne D (2010) Do cytokines induce vascular calcification by the mere stimulation of TNAP activity? Med. Hypotheses 75, 517-521.
13. Mountziaris PM, Tzouanas SN, Mikos AG (2010) Dose effect of tumor necrosis factor-alpha on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds. Biomaterials 31, 1666-1675.
14. Tu Q, Valverde P, Chen J (2006) Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem. Biophys. Res. Commun. 341, 1257-1265.
15. Pan K, Sun Q, Zhang J, Ge S, Li S, Zhao Y et al. (2010) Multilineage differentiation of dental follicle cells and the roles of Runx2 over-expression in enhancing osteoblast/cementoblast-related gene expression in dental follicle cells. Cell Prolif. 43, 219-228.
16. Tu Q, Zhang J, Dong LQ, Saunders E, Luo E, Tang J et al. (2011) Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of AKT1. J. Biol. Chem. 286, 12542-12553.
17. Datta N, Holtorf HL, Sikavitsas VI, Jansen JA, Mikos AG (2005) Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 26, 971-977.
18. Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65.
19. Han D, Ybanez MD, Ahmadi S, Yeh K, Kaplowitz N (2009) Redox regulation of tumor necrosis factor signaling. Antioxid. Redox Signal. 11, 2245-2263.
20. Nanes MS (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321, 1-15.
21. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190.
22. Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR et al. (2006) The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13, 712-729.
23. Shen HM, Pervaiz S (2006b) TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J. 20, 1589-1598.
24. Eda H, Shimada H, Beidler DR, Monahan JB (2010) Proinflammatory cytokines, IL-1beta and TNF-alpha, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-kappaB pathway but not p38 pathway in osteoblasts. Rheumatol. Int. [Epub ahead of print].
25. Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR et al. (2009) Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J. Bone Miner. Res. 24, 1434-1449.
26. Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R et al. (2009) Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat. Med. 15, 682-689.
27. Ruocco MG, Maeda S, Park JM, Lawrence T, Hsu LC, Cao Y et al. (2005) I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201, 1677-1687.
28. Kilian KA, Bugarija B, Lahn BT, Mrksich M (2010) Geometric cues for directing the differentiation of mesenchymal stem cells. Proc. Natl. Acad. Sci. USA 107, 4872-4877.
29. Lee K, Kim H, Kim JM, Kim JR, Kim KJ, Kim YJ et al. (2010) Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function. J. Cell Mol. Med. [Epub ahead of print].
30. Liu H, Liu Y, Viggeswarapu M, Zheng Z, Titus L, Boden SD (2010) Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type I BMP receptor. J. Bone Miner. Res. 26, 1122-1132.
31. Krum SA, Chang J, Miranda-Carboni G, Wang CY (2010) Novel functions for NFkappaB: inhibition of bone formation. Nat. Rev. Rheumatol. 6, 607-611.
32. Shen HM, Liu ZG (2006a) JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 40, 928-939.
33. Wullaert A, Heyninck K, Beyaert R (2006) Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem. Pharmacol. 72, 1090-1101.
34. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J et al. (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141, 3956-3964.